Diabetologische Schwerpunktpraxis - BAG Dr. Täschner/ Dr. Bonigut
- Address
- Gerhard-Ellrodt-Str. 19, 04249 Leipzig, Germany
Cardiovascular Diseases
The research at Diabetologische Schwerpunktpraxis focuses on preventing heart failure by testing new combination therapies that may lower the chance of a cardiovascular event. One study compares baxdrostat added to dapagliflozin against standard treatment to see if it reduces risk. Another examines the role of dapagliflozin alone in heart failure prevention.
- Evaluation of combination drug effects on heart failure risk
- Assessment of cardiovascular mortality outcomes
- Safety profile of added therapy in high‑risk patients
This work supports the site’s commitment to advancing cardiovascular care for patients at risk of developing heart failure.
Nutritional and Metabolic Diseases
In the metabolic program, investigators examine whether a novel oral agent can improve glycemic control for adults with type 2 diabetes. The trial compares the new drug to semaglutide, an established therapy, to assess effectiveness.
- Head‑to‑head comparison with established therapy
- Impact on blood sugar management and weight
- Patient‑reported outcomes and quality of life
The study reflects the practice’s dedication to expanding treatment options for diabetes while ensuring safety and effectiveness.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Diabetologische Schwerpunktpraxis - BAG Dr. Täschner/ Dr. Bonigut
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Baxdrostat and Dapagliflozin on Heart Failure Incidence and Cardiovascular Mortality in High-Risk Patients: A Phase III Randomized Controlled Trial | AstraZeneca AB | Phase III | Recruiting | May 2025 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azd5004 | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.